Nvelop Therapeutics
About:
Nvelop Therapeutics is a biotechnology company that provides gene editing technology services for unmet major disease needs.
Website: https://www.nveloptx.com
Top Investors: F-Prime Capital, Atlas Venture, Newpath Management, 5AM Ventures
Description:
Nvelop Therapeutics is a biotechnology company that provides gene editing technology services for unmet major disease needs.
Total Funding Amount:
$100M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2022-01-01
Founders:
J. Keith Joung
Number of Employees:
11-50
Last Funding Date:
2023-09-25
IPO Status:
Private
Industries:
© 2025 bioDAO.ai